Folding stability of amyloid‐β 40 monomer is an important determinant of the nucleation kinetics in fibrillization

Amyloid formation is initiated by protein misfolding, followed by self‐association to ultimately form amyloid fibrils. The discovery of toxic prefibrillar oligomers in many amyloidosis underscores the importance of understanding the folding mechanism prior to such aggregation. Here, we investigated the folding properties of the natively unfolded amyloid‐β (Aβ) peptide and the familial variants (A21G, E22Q, E22G, E22K, and D23N) in Alzheimer's disease (AD). In combinations of native electrophoresis, analytical ultracentrifugation, fluorescence emission, and far‐UV circular dichroism, we showed that all Aβ40 variants are predominantly monomeric with similar residual secondary structures, but distinct hydrophobic‐exposed protein surfaces. Guanidine hydrochloride (GdnHCl) denaturation in the absence and presence of trifluoroethanol (TFE) showed that Aβ variants adopt an apparent 2‐state equilibrium model with different stabilities, in which wild type is less stable than A21G but more stable than D23N and E22 mutants. By correlating the folding stability with the nucleation phase in fibrillization, we found the more stable the variant, the slower the nucleation, except for D23N. Besides, the unfolding of Aβ conformation leads to reduced formation of mature fibrils, but an increase in nonfibrillar, amorphous type of aggregates. Overall, we demonstrated that folding stability of Aβ is an important determinant of the nucleation kinetics.—Ni, C.‐L., Shi, H.‐P., Yu, H.‐M., Chang, Y.‐C., and Chen, Y.‐R. Folding stability of amyloid‐β 40 monomer is an important determinant of the nucleation kinetics in fibrillization. FASEB J. 25, 1390–1401 (2011). www.fasebj.org

[1]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[2]  V. Uversky,et al.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.

[3]  Jun-tao Guo,et al.  Molecular modeling of the core of Abeta amyloid fibrils. , 2004, Proteins.

[4]  John Q Trojanowski,et al.  Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.

[5]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.

[6]  Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein. , 2008, Journal of molecular biology.

[7]  P. Scheltens,et al.  Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same? , 2005, Annals of neurology.

[8]  Sheena E Radford,et al.  The Yin and Yang of protein folding , 2005, The FEBS journal.

[9]  A. Mark,et al.  Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: A molecular dynamics study , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[11]  D. Teplow,et al.  On the nucleation of amyloid β‐protein monomer folding , 2005 .

[12]  D. Selkoe,et al.  Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin , 2008, Neurobiology of Disease.

[13]  G. Weber,et al.  Dimer formation from 1-amino-8-naphthalenesulfonate catalyzed by bovine serum albumin. A new fluorescent molecule with exceptional binding properties. , 1969, Biochemistry.

[14]  J. Kelly,et al.  Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Levine.  4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonate: report on non-β-sheet conformers of Alzheimer's peptide β(1-40) , 2002 .

[16]  Jun-tao Guo,et al.  Molecular modeling of the core of Aβ amyloid fibrils , 2004 .

[17]  D. Teplow,et al.  Familial Alzheimer's disease mutations alter the stability of the amyloid β-protein monomer folding nucleus , 2007, Proceedings of the National Academy of Sciences.

[18]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Ying Xu,et al.  Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.

[20]  H. Levine.  4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40). , 2002, Archives of biochemistry and biophysics.

[21]  R. Tycko,et al.  Molecular structure of amyloid fibrils: insights from solid-state NMR , 2006, Quarterly Reviews of Biophysics.

[22]  M. Howard,et al.  Comparison of the effects of 2,2,2-trifluoroethanol on peptide and protein structure and function. , 2007, Journal of structural biology.

[23]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.

[25]  D. Teplow,et al.  On the nucleation of amyloid beta-protein monomer folding. , 2005, Protein science : a publication of the Protein Society.

[26]  R. Roos,et al.  Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects , 1996, Brain pathology.

[27]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[28]  R. Riek,et al.  NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox). , 2001, European journal of biochemistry.

[29]  D. Selkoe,et al.  Deciphering the genetic basis of Alzheimer's disease. , 2002, Annual review of genomics and human genetics.

[30]  J. Brewer,et al.  Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation , 2004 .

[31]  D Thirumalai,et al.  Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions. , 2008, Journal of molecular biology.

[32]  P. A. Evans,et al.  Kinetics of interaction of partially folded proteins with a hydrophobic dye: Evidence that molten globule character is maximal in early folding intermediates , 1995, Protein science : a publication of the Protein Society.

[33]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[34]  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[35]  L. Juliano,et al.  Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. , 2005, The Journal of biological chemistry.

[36]  Carl Frieden.  Protein aggregation processes: In search of the mechanism , 2007, Protein science : a publication of the Protein Society.

[37]  D. Teplow,et al.  Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[38]  R. Tycko,et al.  Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. , 2005, Biochemistry.

[39]  D. Teplow,et al.  Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.

[40]  B. Strooper,et al.  In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity , 2002, Neurobiology of Disease.

[41]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[42]  H. Weiner,et al.  Immunology and immunotherapy of Alzheimer's disease , 2006, Nature Reviews Immunology.

[43]  R. Tycko,et al.  Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. , 2009, Biochemistry.

[44]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[45]  Yun-Ru Chen,et al.  Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. , 2006, The Journal of biological chemistry.

[46]  T. Grabowski,et al.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.

[47]  Yun-Ru Chen,et al.  Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42 , 2006, Journal of Biological Chemistry.

[48]  P. Scheltens,et al.  Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same? , 2005 .

[49]  Ralf Langen,et al.  Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling* , 2002, The Journal of Biological Chemistry.

[50]  J. Hardy,et al.  Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.

[51]  J. Brewer,et al.  Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. , 2004, Journal of the American Chemical Society.

[52]  C. van Broeckhoven,et al.  Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. , 1998, Neurobiology of disease.

[53]  Yue-Ming Li,et al.  An APP inhibitory domain containing the Flemish mutation residue modulates γ-secretase activity for Aβ production , 2010, Nature Structural &Molecular Biology.

[54]  Ulrich Baxa,et al.  β arcades: recurring motifs in naturally occurring and disease‐related amyloid fibrils , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  Johannes Kornhuber,et al.  Blood‐based neurochemical diagnosis of vascular dementia: a pilot study , 2007, Journal of neurochemistry.

[56]  D. Teplow,et al.  Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. , 2008, Journal of molecular biology.

[57]  G. Weber,et al.  Dimer formation from 1-anilino-8-naphthalenesulfonate catalyzed by bovine serum albumin. Fluorescent molecule with exceptional binding properties , 1969 .

[58]  L. Brand,et al.  Fluorescence probes for structure. , 1972, Annual review of biochemistry.

[59]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[60]  E. Wijsman,et al.  Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. , 1992, American journal of human genetics.

[61]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.